Cargando…

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

BACKGROUND: Gene expression of specific therapeutic targets in non-malignant lung tissue might play an important role in optimizing targeted therapies. This study aims to identify different expression patterns of fifteen genes important for targeted therapy in non-small cell lung cancer (NSCLC). MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynders, Kobe, Wauters, Els, Moisse, Matthieu, Decaluwé, Herbert, De Leyn, Paul, Peeters, Stéphanie, Lambrecht, Maarten, Nackaerts, Kristiaan, Dooms, Christophe, Janssens, Wim, Vansteenkiste, Johan, Lambrechts, Diether, De Ruysscher, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050654/ https://www.ncbi.nlm.nih.gov/pubmed/30016964 http://dx.doi.org/10.1186/s13014-018-1075-1

Ejemplares similares

Pembrolizumab-induced necrotizing myositis in a patient with metastatic non-small-cell lung cancer: a case report
por: Claus, Jonas, et al.
Publicado: (2019)

Value of [(68)Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature
por: Deleu, Anne-Leen, et al.
Publicado: (2022)

Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis
por: Franken, Amelie, et al.
Publicado: (2022)

Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages?
por: Deslypere, Griet, et al.
Publicado: (2018)

Invasive mediastinal staging by endosonography or video-assisted mediastinoscopy in PET-CT clinical N1 non-small cell lung cancer
por: Decaluwé, Herbert, et al.
Publicado: (2020)

Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives
por: Oliveri, Serena, et al.
Publicado: (2023)

LBA78 A microsimulation model to assess the impact of SARS-CoV-2 on cancer outcomes, healthcare organization and economic burden
por: Van Mol, P., et al.
Publicado: (2020)

LBA81 Keeping exhausted T-cells in check in COVID-19
por: Van Mol, P., et al.
Publicado: (2020)

Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study
por: Vaes, Rianne D. W., et al.
Publicado: (2021)

Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
por: Kreuter, Michael, et al.
Publicado: (2007)

Performance of standard procedures in detection of EGFR mutations in daily practice in advanced NSCLC patients selected according to the ESMO guideline: a large Caucasian cohort study
por: Hantson, Inge, et al.
Publicado: (2014)

Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting
por: Monzani, Dario, et al.
Publicado: (2021)

Lung Aeration in COVID-19 Pneumonia by Ultrasonography and Computed Tomography
por: Kalkanis, Alexandros, et al.
Publicado: (2022)

Variants in the 15q24/25 Locus Associate with Lung Function Decline in Active Smokers
por: Mohamed Hoesein, Firdaus A. A., et al.
Publicado: (2013)

Impact of the extent of lung resection on postoperative outcomes of pulmonary metastasectomy for colorectal cancer metastases: an exploratory systematic review
por: Prisciandaro, Elena, et al.
Publicado: (2022)

An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
por: Vanneste, Ben G. L., et al.
Publicado: (2021)

Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018)

Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis
por: Herdewyn, Sarah, et al.
Publicado: (2012)

Evolving target volume concepts in locally advanced non-small cell lung cancer
por: Nestle, Ursula, et al.
Publicado: (2021)

Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19
por: Ceulemans, Laurens J, et al.
Publicado: (2021)

Testing of human papillomavirus in lung cancer and non-tumor lung tissue
por: Galvan, Antonella, et al.
Publicado: (2012)

Cigarette smoke alters the transcriptome of non-involved lung tissue in lung adenocarcinoma patients
por: Pintarelli, Giulia, et al.
Publicado: (2019)

Prophylactic cranial irradiation (PCI) in locally advanced non-small cell lung cancer: time for hope?
por: De Ruysscher, Dirk K., et al.
Publicado: (2018)

Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer Patients
por: Durosini, Ilaria, et al.
Publicado: (2021)

Prognostic implications of cellular senescence in resected non-small cell lung cancer
por: Domen, Andreas, et al.
Publicado: (2022)

What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences
por: Petrocchi, Serena, et al.
Publicado: (2021)

Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy
por: Janssens, Rosanne, et al.
Publicado: (2021)

Soft tissue metastases of non-small cell lung cancer
por: Tiresse, Nabil, et al.
Publicado: (2021)

ESR/ERS white paper on lung cancer screening
por: Kauczor, Hans-Ulrich, et al.
Publicado: (2015)

ESR/ERS white paper on lung cancer screening
por: Kauczor, Hans-Ulrich, et al.
Publicado: (2015)

Therapeutic Drug Monitoring of Meropenem in Neonate with Necrotizing Enterocolitis: A Challenge
por: De Keukeleire, Steven, et al.
Publicado: (2016)

Early lung ultrasound assessment for the prognosis of patients hospitalized for COVID-19 pneumonia. A pilot study
por: Kalkanis, A., et al.
Publicado: (2021)

Immunotherapy in lung cancer
por: Vansteenkiste, Johan F
Publicado: (2018)

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
por: Kim, Jiyeon, et al.
Publicado: (2017)

Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
por: Lloréns-Rico, Verónica, et al.
Publicado: (2021)

Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?
por: Peeters, Stephanie T. H., et al.
Publicado: (2021)

Altered lung tissue lipidomic profile in caspase-4 positive non-small cell lung cancer (NSCLC) patients
por: Terlizzi, Michela, et al.
Publicado: (2020)

CTLA-4 Expression and Polymorphisms in Lung Tissue of Patients with Diagnosed Non-Small-Cell Lung Cancer
por: Antczak, Adam, et al.
Publicado: (2013)

Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer
por: del Mar Valenzuela-Membrives, María, et al.
Publicado: (2016)

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sig7goqiamedbugd0hjq7mjquu